[1]
SampaioL. S., SilvaA. M. da, AguiarL. C. T., ChavesS. K. M., NunesA. M. V., and BrazD. C., “IL-6 concentration in patients with rheumatoid arthritis treated with tocilizumab: integrative review”, EJCH, vol. 15, no. 5, p. e10176, May 2022.